Grant History

The $5.1M of total grant support we've given to funding research is made possible by the generosity of our sponsors and donors. Real people making an impact on saving children's eyesight.

Grant Amount

$3M
2024
$2.1M

2025

Year
Grant Amount
Month
Amount/ month
Purpose

2026

$1.1M

January
$1.1M

To close the remaining funding gap required to launch the AXV-101 clinical trial, enabling the study to begin in early 2026.

2025

$1M

September
$1M

To support clinical development of the first-in-human trial, including trial preparation and regulatory progress following clinical trial clearance.

2024

$3M

October
$1M
December
$2M

To fund the preclinical development and regulatory preparation of AXV-101, a gene therapy for Bardet-Biedl Syndrome type 1 (BBS1), advancing the program toward its first human clinical trial.

News and Articles

Recent News
January 06, 2026
A Race Against Blindness Awards Additional $1.1 Million Grant to Ensure Advancement of AXV-101 into Clinical Trial for Bardet-Biedl Syndrome 1 (BBS1)

Newly added funding closes critical gap and enables planned trial initiation in early 2026

Read More
A Race Against Blindness Awards Additional $1.1 Million Grant to Ensure Advancement of AXV-101 into Clinical Trial for Bardet-Biedl Syndrome 1 (BBS1)

Latest Posts

Community Stories April 08, 2026
From El Tour to Today: Continuing the Race Against Blindness

A few years after El Tour first shared their story, A Race Against Blindness returns to Southern Arizona for El Tour de Zona. This personal reflection explores progress, purpose, and why the ride still matters.

Read More
Gratitude Gallery March 23, 2026
🧡 Gratitude Gallery: From Hopelessness to Hope: A Community Moving the Needle

Supporters share heartfelt messages of hope, personal stories, and encouragement as a clinical trial milestone brings new possibility to children facing blindness.

Read More
Community Stories March 16, 2026
Two Winners, One Drive for Vision Research
Read More